Full text

Turn on search term navigation

Copyright © 2018 Wen Ju et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/

Abstract

Endothelial cells (ECs) could express some important cytokines and signal molecules which play a key role in normal hematopoiesis and repopulation. Busulfan-induced vascular endothelial injury is an important feature after hematopoietic stem cell transplantation (HSCT). But the molecular mechanism of how the injured ECs affect hematopoietic reconstruction is still unknown. It is possibly through modulation of the change of some gene expression. RT-qPCR is one of the most popular methods used to accurately determine gene expression levels, based on stable reference gene (RG) selection from housekeeping genes. So our aim is to select stable RGs for more accurate measures of mRNA levels during Busulfan-induced vascular endothelial injury. In this study, 14 RGs were selected to investigate their expression stability in ECs during 72 hours of EC injury treated with Busulfan. Our results revealed extreme variation in RG stability compared by five statistical algorithms. ywhaz and alas1 were recognized as the two idlest RGs on account of the final ranking, while the two most usually used RGs (gapdh and actb) were not the most stable RGs. Next, these data were verified by testing signalling pathway genes ctnnb1, robo4, and notch1 based on the above four genes ywha, alas1, gapdh, and actb. It shows that the normalization of mRNA expression data using unstable RGs greatly affects gene fold change, which means the reliability of the biological conclusions is questionable. Based on the best RGs used, we also found that robo4 is significantly overexpressed in Busulfan-impaired ECs. In conclusion, our data reaffirms the importance of RGs selection for the valid analysis of gene expression in Busulfan-impaired ECs. And it also provides very useful guidance and basis for more accurate differential expression gene screening and future expanding biomolecule study of different drugs such as cyclophosphamide and fludarabine-injured ECs.

Details

Title
Validation of Housekeeping Genes as Reference for Reverse-Transcription-qPCR Analysis in Busulfan-Injured Microvascular Endothelial Cells
Author
Ju, Wen 1 ; Alhaji Osman Smith 2 ; Sun, Tiantian 2 ; Zhao, Pingping 3 ; Jiang, Yan 3 ; Liu, Lu 3 ; Zhang, Ting 3 ; Qi, Kunming 4 ; Qiao, Jianlin 1   VIAFID ORCID Logo  ; Xu, Kailin 1   VIAFID ORCID Logo  ; Zeng, Lingyu 1   VIAFID ORCID Logo 

 Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou 221002, China; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221002, China 
 Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou 221002, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221002, China 
 Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou 221002, China 
 Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China; Blood Diseases Institute, Xuzhou Medical University, Xuzhou 221002, China 
Editor
Lap Ho
Publication year
2018
Publication date
2018
Publisher
John Wiley & Sons, Inc.
ISSN
23146133
e-ISSN
23146141
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2120106757
Copyright
Copyright © 2018 Wen Ju et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/